News

World leaders in breath analysis will showcase its Gastrolyzer® range at one of the leading international events for digestive health. Bedfont® Scientific Limited, a world leader in breath analysis with 50 years of industry experience, is pleased to attend this...

Smokerlyzer® registration with Medicah S.A.S in Colombia boosts quit-smoking services in the region. Bedfont® Scientific Limited, an innovative MedTech company with nearly 50 years of experience in the breath analysis industry, is pleased to collaborate with Medicah S.A.S through a...

Bedfont®, a world leader in breath analysis, has been recognised as one of Investec Direct Lending's selected investments for 2025 following Keensight Capital's majority investment in the company. The inclusion highlights Bedfont's position as a leading UK medical technology innovator...

Showcasing the NObreath® and Smokerlyzer® range while connecting with research teams and global distribution partners at Europe's leading respiratory congress. Bedfont® Scientific Limited, a world leader in breath analysis, is excited to be attending this year's European Respiratory Society (ERS)...

The Gastrolyzer® forum has now been replaced by our Gastrolyzer® Educational Portal. The forum previously provided a space for healthcare professionals using the Gastrolyzer® devices to communicate and share knowledge. The updated Gastrolyzer® Educational Portal has been designed to offer...

Traditionally, people associate quitting smoking with national events like Stoptober and New Year's resolutions, but quitting smoking doesn’t have to wait until then. As the summer holiday season draws to an end and people settle back into everyday routines, late...